JP2023512025A5 - - Google Patents
Info
- Publication number
- JP2023512025A5 JP2023512025A5 JP2022546019A JP2022546019A JP2023512025A5 JP 2023512025 A5 JP2023512025 A5 JP 2023512025A5 JP 2022546019 A JP2022546019 A JP 2022546019A JP 2022546019 A JP2022546019 A JP 2022546019A JP 2023512025 A5 JP2023512025 A5 JP 2023512025A5
- Authority
- JP
- Japan
- Prior art keywords
- rhodatristat
- ethyl
- compound
- item
- certain amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062968651P | 2020-01-31 | 2020-01-31 | |
| US62/968,651 | 2020-01-31 | ||
| PCT/IB2021/000046 WO2021152398A1 (en) | 2020-01-31 | 2021-01-29 | Dosages and methods for treating pulmonary arterial hypertension with rodatristat |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023512025A JP2023512025A (ja) | 2023-03-23 |
| JP2023512025A5 true JP2023512025A5 (cg-RX-API-DMAC7.html) | 2024-01-25 |
Family
ID=75143674
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022546019A Pending JP2023512025A (ja) | 2020-01-31 | 2021-01-29 | 肺動脈性肺高血圧症をロダトリスタットで処置するための投与量および方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230074252A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4096633A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023512025A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220156813A (cg-RX-API-DMAC7.html) |
| CN (1) | CN115379825A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021212355A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3165432A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2022009254A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021152398A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11413287B2 (en) | 2018-11-16 | 2022-08-16 | Altavant Sciences Gmbh | Method for treating pulmonary arterial hypertension and associated pulmonary arterial hypertension |
| WO2023062595A1 (en) * | 2021-10-14 | 2023-04-20 | Altavant Sciences Gmbh | Treatment of subjects having pulmonary arterial hypertension with rodatristat ethyl |
| WO2023079486A1 (en) * | 2021-11-03 | 2023-05-11 | Altavant Sciences Gmbh | Treatment of pulmonary arterial hypertension with rodatristat and ambrisentan |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA119247C2 (uk) | 2013-09-06 | 2019-05-27 | РОЙВЕНТ САЙЕНСИЗ ҐмбГ | Спіроциклічні сполуки як інгібітори триптофангідроксилази |
| CA3119912A1 (en) * | 2018-11-14 | 2020-05-22 | Altavant Sciences Gmbh | A crystalline spirocyclic compound inhibitor of tryptophan hydroxylase 1 (tph1) for treating diseases or disorders associated with peripheral serotonin |
-
2021
- 2021-01-29 CN CN202180021555.2A patent/CN115379825A/zh not_active Withdrawn
- 2021-01-29 WO PCT/IB2021/000046 patent/WO2021152398A1/en not_active Ceased
- 2021-01-29 AU AU2021212355A patent/AU2021212355A1/en not_active Abandoned
- 2021-01-29 KR KR1020227030098A patent/KR20220156813A/ko not_active Withdrawn
- 2021-01-29 EP EP21713735.5A patent/EP4096633A1/en not_active Withdrawn
- 2021-01-29 JP JP2022546019A patent/JP2023512025A/ja active Pending
- 2021-01-29 MX MX2022009254A patent/MX2022009254A/es unknown
- 2021-01-29 US US17/759,700 patent/US20230074252A1/en not_active Abandoned
- 2021-01-29 CA CA3165432A patent/CA3165432A1/en active Pending